Switching antipsychotics. Antipsychotic tolerance, withdrawal and relapse: Unresolved issues and research implications

Journal of Psychopharmacology

Volumn 22, Issue 7, 2008, Pages 815-817

  Goudie, A J ^a   Cole, J C ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; CLOZAPINE; LORAZEPAM; METHYLPHENIDATE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

CROSS TOLERANCE; DRUG EFFECT; DRUG SUBSTITUTION; DRUG TOLERANCE; DRUG WITHDRAWAL; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOSIS; RELAPSE; TREATMENT RESPONSE; WITHDRAWAL SYNDROME;

ANTIPSYCHOTIC AGENTS; DRUG TOLERANCE; HUMANS; PSYCHOTIC DISORDERS; RECURRENCE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 50249121221     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881107082904     Document Type: Letter

References (29)

1. Aceto M. (1990) Assessment of physical dependence techniques for the evaluation of abused drugs. In Adler M W, Cowen A (eds). Testing and evaluation of drugs of abuse. Willey-Liss, New York, pp. 67-79
2. Aranko K., Mattila J., Nuutila A., Pellinen J. (1985). Benzodiazepines, but not antidepressants or neuroleptics, induce dose-dependant tolerance to lorazepam in psychiatric patients. Acta Psychiatr Scand 72: 436-46
3. Baldessarini R., Viguera A., Tondo L. (1999 a) Discontinuing psychotropic agents. J Psychopharmacol 13: 292-3
4. Baldessarini R., Tondo L., Viguera A. (1999 b) Discontinuing lithium maintenance treatment in bipolar disorder: Risks and implications. Bipolar Disorders 1: 17-24
5. Chue P., Stip E., Remington G., Kopala L. (2004) Switching antipsychotics: a review. Acta Neuropsychiatr 16: 301-13
6. Davis J., Marder S., Tamminga C. (2006) Switch or stay? Am J Psychiatry 163: 2032-3
7. Essock S., Covell N., Davis S., Stroup T., Rosenheck R., Lieberman J. (2006) Effectiveness of switching antipsychotics. Am J Psychiatry 163: 2090-5
8. Fernandez H., Trieschmann, M., Okun M. (2005) Rebound psychoses: Effect of discontinuation of antipsychotics in Parkinson's disease. Movement Disorders 20: 104-15
9. Gerlach J., Koppelhus P., Helweg E., Manrad A. (1974) Clozapine and haloperidol in a single-blind cross-over trial. Therapeutic and biochemical aspects in the treatment of schizophrenia. Acta Psychiatr Scand 50: 410-24
10. Goudie A. (2000) What is the clinical significance of the discontinuation syndrome seen with clozapine? J Psychopharmacol 14: 188-92
11. Goudie A., Smith J., Robertson A., Cavanagh C. (1999) Clozapine as a drug of dependence. Psychopharmacology 142: 369-74
12. Goudie A., Cooper G., Cole J., Sumnall H. (2007 a) Cyproheptadine resembles clozapine in vivo following both acute and chronic administration in rats. J Psychopharmacol 21: 171-90
13. Goudie A., Cole J., Sumnall H. (2007 b) Olanzapine and JL 13 induce cross-tolerance to the clozapine discriminative stimulus in rats. Behav Pharmacol 18: 9-17
14. Goudie A., Cole J., Sumnall H. (2007 c) Olanzapine withdrawal/ discontinuation-induced hyperthermia in rats. Progress in Neuropsychopharmacology and Biological Psychiatry 31: 1500-03
15. Grassi B., Ferrari R., Epifani M., Dragoni C., Cohen S., Scarone S. (1999) Clozapine lacks previous clinical efficacy when restarted after a period of discontinuation: a case series. Eur Neuropsychopharmacol 9: 479-81
16. Haro J, Novick D, Belger M, Jones P, SOHO Advisory Board (2006) Antipsychotic type and correlates of antipsychotic treatment discontinuation in the outpatient treatment of schizophrenia. Eur Psychiatry 21: 41-7
17. Lieberman J., Stroup T., McEvoy J., Swartz M., Rosenheck R., Perkins D., Keefe R., Davis S., Davis C., Lebowitz B., Severe J., Hsiao J. (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England J Med 353: 1209-23
18. Llorca P., Vaiva G., Lancon C. (2001) Supersensitivity psychosis in patients after sudden olanzapine withdrawal. Can J Psychiatry 46: 87-8
19. Margolese H., Chouinard G., Beauclair L., Bellanger M-C. (2002) Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients. J Clin Psychopharmacol 20: 489-90
20. Meltzer H., Lee M., Ranjan R., Mason E., Cola P. (1996). Relapse following clozapine withdrawal. Psychopharmacology 124: 176-87
21. Miodownik C., Lerner V., Kibari A., Toder D., Cohen H. (2006) The effect of sudden clozapine discontinuation on management of schizophrenic patients: a retrospective controlled study. J Clin Psychiatry 67: 1204-8
22. National Collaborating Centre for Mental Health (2003) Full national clinical guidelines on core interventions in primary and secondary care for schizophrenia. Gaskell and British Psychological Society, London and Leicester, ISBN 1-901242-97- 8
23. Nayudu S., Scheftner W. (2000) Case report of withdrawal syndrome after olanzapine discontinuation. J Clin Psychopharmacol 20: 489-90
24. Sabuncuoglu O. (2007) Risperidone to methylphenidate switch reaction in children: three cases. J Psychopharmacol 21: 216-9
25. Samaha A., Seeman P., Stewart J., Rajabi H., Kapur S. (2007) " Breakthrough" dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time. J Neuroscience 27: 2979-86
26. Seppala N., Kovio C., Leinonen E. (2005) Effects of anticholinergic drugs in preventing acute deterioration in patients undergoing abrupt clozapine withdrawal. CNS Drugs 19: 1049-55
27. Tollefson G., Dellva M., Mattler C., Kane J., Wirshing D., Kinon B. (1999) Controlled double-blind investigation of clozapine discontinuation symptoms with conversion to either olanzapine or placebo. J Clin Psychopharmacol 19: 435-43
28. Viguera A., Baldessarini R., Hegarty J., Van Kammen D., Tohen M. (1997) Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Arch Gen Psychiatry 54: 49-55
29. Weiden P. (2006) Switching antipsychotics: an updated review with a focus on quetiapine. J Psychopharmacol 20: 104-8